| Literature DB >> 15520847 |
Abstract
Patients requiring prolonged intensive care are at high risk for multiple organ failure and death. Insulin resistance and hyperglycemia accompany critical illness, and the severity of this "diabetes of stress" reflects the risk of death. Recently it was shown that preventing hyperglycemia with insulin substantially improves outcome of critical illness. This article examines some potential mechanisms underlying prevention of glucose toxicity as well as the effects of insulin independent of glucose control. Unraveling the molecular mechanisms will provide new insights into the pathogenesis of multiple organ failure and open avenues for novel therapeutic strategies.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15520847 PMCID: PMC524243 DOI: 10.1172/JCI23506
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808